Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Accuray Incorporated (DE:XEJ)
FRANKFURT:XEJ
Holding DE:XEJ?
Track your performance easily
XEJ Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€1.37 - €3.86
Previous Close€1.79
Volume0.00
Average Volume (3M)875.00
Market Cap
€179.53M
Enterprise Value€298.41M
Total Cash (Recent Filing)$72.76M
Total Debt (Recent Filing)$202.22M
Price to Earnings (P/E)―
Beta0.83
Next Earnings
Aug 15, 2024EPS Estimate
€0.03Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding99,244,173
10 Day Avg. Volume0
30 Day Avg. Volume875
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)3.50
Price to Sales (P/S)0.37
Price to Cash Flow (P/CF)-9.20
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.67
Enterprise Value/Gross Profit1.94
Enterprise Value/Ebitda168.78
Forecast
1Y Price Target
€5.81Price Target Upside224.72% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering3
Accuray News
PremiumCompany Announcements
Accuray Announces CEO Medical Leave and Interim Successor
PremiumCompany Announcements
Accuray Provides Investor Presentation with Financial Insights
Bulls Say, Bears Say
Bulls Say
China Market PotentialChina has the potential to become a massive positive as the Company is poised to become the leader in this huge emerging market.
Gross Product OrdersGross product orders reached $89.1M, significantly surpassing the previous $73.8M.
International GrowthARAY saw strong international growth, with a 21% global order growth and a 4% year-over-year increase in the global installed base.
Bears Say
Capital SpendingU.S. hospitals pulled back capital spending for radiotherapy equipment, impacting margins.
GuidanceManagement lowered 2024 guidance, with revenue estimated to be in the range of $432M-$437M and AEBITDA expected to be in the range of $19M-$22M.
RevenueQ3 revenue of $101.1M was below forecast and consensus.
---
Options Prices
Currently, No data available
---
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
0.63% Other Institutional Investors
99.37% Public Companies and
Individual Investors
XEJ FAQ
What was Accuray Incorporated’s price range in the past 12 months?
Accuray Incorporated lowest stock price was €1.37 and its highest was €3.86 in the past 12 months.
What is Accuray Incorporated’s market cap?
Currently, no data Available
When is Accuray Incorporated’s upcoming earnings report date?
Accuray Incorporated’s upcoming earnings report date is Aug 15, 2024 which is 37 days ago.
How were Accuray Incorporated’s earnings last quarter?
Accuray Incorporated released its earnings results on May 01, 2024. The company reported -€0.055 earnings per share for the quarter, missing the consensus estimate of -€0.011 by -€0.044.
Is Accuray Incorporated overvalued?
According to Wall Street analysts Accuray Incorporated’s price is currently Undervalued.
Does Accuray Incorporated pay dividends?
Accuray Incorporated does not currently pay dividends.
What is Accuray Incorporated’s EPS estimate?
Accuray Incorporated’s EPS estimate is €0.03.
How many shares outstanding does Accuray Incorporated have?
Currently, no data Available
What happened to Accuray Incorporated’s price movement after its last earnings report?
Accuray Incorporated reported an EPS of -€0.055 in its last earnings report, missing expectations of -€0.011. Following the earnings report the stock price went down -3.279%.
Which hedge fund is a major shareholder of Accuray Incorporated?
Among the largest hedge funds holding Accuray Incorporated’s share is Royce & Associates LLC. It holds Accuray Incorporated’s shares valued at 8M.
---
Accuray Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
€5.81 (224.72% Upside)
€5.81 (224.72% Upside)
Blogger Sentiment
Bullish
DE:XEJ Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Bought Shares
Worth $156.0K over
the Last 3 Months
the Last 3 Months
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-48.96%
12-Months-Change
Fundamentals
Return on Equity
-44.87%
Trailing 12-Months
Asset Growth
-2.77%
Trailing 12-Months
Company Description
Accuray Incorporated
Accuray, Inc. is a radiation oncology company. It engages in the development, manufacture and sale of treatment solutions that includes cyberKnife and tomo therapy systems, designed to deliver radiosurgery, stereotactic body radiation therapy, intensity modulated radiation therapy, image-guided radiation therapy and adaptive radiation therapy. The company was founded by John R. Adler in 1990 and is headquartered in Sunnyvale, CA.
---
XEJ Company Deck
---
XEJ Earnings Call
Q3 2024
0:00 / 0:00
---
XEJ Stock 12 Month Forecast
Average Price Target
€5.81
▲(224.72% Upside)
Technical Analysis
Accuray
―
Intuitive Surgical
―
Ardelyx
―
Arvinas Holding Company
―
Arcturus Therapeutics
―
Best Analysts Covering XEJ
1 Year
1 Year Success Rate
11/23 ratings generated profit
1 Year Average Return
+5.47%
reiterated a buy rating 5 months ago
Copying Marie Thibault's trades and holding each position for 1 Year would result in 47.83% of your transactions generating a profit, with an average return of +5.47% per trade.
---